Scientists finally reveal how this Alzheimer’s drug really works
Lecanemab, marketed as Leqembi, is a monoclonal antibody treatment for Alzheimer’s disease that targets and removes harmful amyloid plaques while slowing cognitive decline. Scientists from VIB and KU Leuven have…